[Table/Fig-7]:
Secondary end points, 3 month after enrolment including change from baseline.
| At 3 month | Crude change from baseline | Treatment effect (95% confidence interval) |
Statistical significance (p-value) |
|||||
|---|---|---|---|---|---|---|---|---|
| Steroid n=47 (SD) |
Saline n=46 (SD) |
Steroid n=47 (SD) |
Statistical significance |
Saline n=46 (SD) |
Statistical significance |
|||
| Pain VAS (mm) | 34.83 (20.34) | 45.78 (23.60) | -34.26 (19.34) | Yes | -21.65 (20.53) | Yes | -12.61 (-20.82 to -4.40) | Yes (p=0.003) |
| SLR test (degree) | 58.94 (20.3) | 48.91(21.98) | 10.53 (19.82) | Yes | 3.26 (14.99) | No | 7.27 (0.02 to 14.52) | Yes (p=0.0494) |
| Schober’s test (cm) | 3.13 (0.61) | 3.10 (0.64) | 0.72 (0.49) | Yes | 0.67(0.52) | Yes | 0.05 (-0.16 to 0.26) | No (p=0.64) |
| Roland Morris Index | 11.51 (5.03) | 13.96 (4.09) | -5.66 (4.93) | Yes | -3.13(3.80) | Yes | -2.53(-4.35 to -0.71) | Yes (p=0.007) |
| Oswestry Disability Index | 35.15 (10.19) | 40.20 (8.41) | -11.30 (10.05) | Yes | -6.15(8.04) | Yes | -5.15(-8.90 to -1.40) | Yes (p=0.008) |